The main problem is that most vector production technologies were developed for the lab, rather than to support industrial ...

The Viral Vector & Plasmid DNA Manufacturing Market Size accounted for USD 5.4 Billion in 2023 and is estimated to achieve a ...

Strategic appointments advance Addgene’s growth and market expansion strategyWATERTOWN, Mass., April 16, 2025 (GLOBE NEWSWIRE) -- Addgene, an organization empowering discovery by providing scientists ...

ViroCell Biologics ("ViroCell" or the "Company"), a specialist viral vector Contract Development and Manufacturing Organisation ("CDMO") for cell and gene therapy (CGT) clinical trials, announces the ...

Researchers have developed novel lymph-node-inspired hydrogels that significantly enhance the activation, gene expression, ...

A team of researchers from Japan have developed a hydrogel that successfully reverted cancer cells back to cancer stem cells.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

Delve into the landscape of biotech companies developing treatments for HIV and find out if we are getting closer to a cure.

Porton Advanced proudly announces its CDMO support for TASLY PHARMACEUTICAL CO., LTD's Innovative Dual-Targeting CAR-T Therapy, "P134 Cell Injection," which has received Investigational New Drug (IND) ...

Scientists have identified a previously unknown type of neural stem cell (pNSC) that exists outside the brain and spinal cord ...

Epidemiologist Elizabeth Schiffman, who supervises the Vectorborne Diseases Unit at the Minnesota Department of Health, ...